Dietary Management of Chronic Diarrhoea: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:

Chronic diarrhoea affects up to 14% of adults, it impacts on quality of life and its cause can be variable. Patients with chronic diarrhoea are presented with a plethora of dietary recommendations, often sought from the internet or provided by those who are untrained or inexperienced. Once a diagnosis is made, or serious diagnoses are excluded, dietitians play a key role in the management of chronic diarrhoea. The dietitian’s role varies depending on the underlying cause of the diarrhoea, with a wide range of dietary therapies available. Dietitians also have an important role in educating patients about the perils and pitfalls of dietary therapy.

  • chronic diarrhoea
  • diet
  • irritable bowel syndrome
  • FODMAP
  • SIBO
  • lactose intolerance
  • bile acid diarrhoea
  • sucrase-isomaltase deficiency
  • dietitian

1. Introduction

Chronic diarrhoea is variably defined but usually includes stools ranging from type 5 to type 7 on the Bristol stool form scale, a duration of more than four weeks, and frequency of stools (usually >25% of the time) [1]. The prevalence of chronic diarrhoea is difficult to determine due to these definition variations [2]. In a population of older adults, 14% were classified as having chronic diarrhoea based on increased stool frequency and the absence of abdominal pain [3]. However, this may include patients with structural or functional causes such as microscopic colitis or chronic diseases such as diabetes. A population-based study from the United States using a validated bowel health questionnaire based on the Bristol stool form scale, reported a prevalence of 6.6% in the adult American population [2].

When dietitians are faced with patients with chronic diarrhoea, it is imperative that a diagnosis is pursued and that sinister diagnoses are excluded. This will involve referral to, and collaboration with, the patient’s General Practitioner or Gastroenterologist. Alarm features that suggest more worrying diagnoses include rectal bleeding, symptoms that wake the patient from sleep, unintentional weight loss, severe unremitting symptoms, a family history of inflammatory bowel disease or colorectal cancer and onset of new symptoms in a patient over the age of 50 years. However, patients without alarm symptoms may also need to undergo appropriate investigations.

Non-invasive investigations could include a full blood count, urea and electrolytes, coeliac serology, iron, vitamin B12 and folate, faecal culture and parasites. A measure of pancreatic exocrine function (e.g., faecal fat concentration or elastase) can be pursued if steatorrhoea is suspected. If indicated, colonoscopy with mucosal biopsy is the gold-standard test to diagnose serious ileocolonic pathology including colorectal cancer, microscopic colitis and inflammatory bowel disease. Other testing can be helpful in specific circumstances including hydrogen and methane breath testing for carbohydrate malabsorption and small intestinal bacterial overgrowth.

Once a diagnosis is made, or serious diagnoses are excluded, dietitians play a key role in the management of chronic diarrhoea. Often the cause may be functional and can lead to a diagnosis of functional diarrhoea (FD) or diarrhoea-predominant irritable bowel syndrome (IBS-D) (Table 1). The dietitian’s role varies depending on the underlying cause of the diarrhoea, with a wide range of dietary therapies available. However, dietitians also have an important role in educating patients about the perils and pitfalls of dietary therapy. Depending upon the cause, if left untreated, chronic diarrhoea may lead to malnutrition and micronutrient deficiencies [4]. Likewise, micronutrient deficiencies may occur when foods or food groups are removed to manage symptoms without considering diet adequacy [5]. Chronic diarrhoea may also impact on quality of life, with increased incidence of depression described in populations of both young [2] and older adults [6].

Table 1. Rome IV criteria for irritable bowel syndrome and functional diarrhoea.

Rome IV Criteria for Irritable Bowel Syndrome–D, M Rome IV Criteria for Functional Diarrhoea
Abdominal pain on average at least 1 day/week in the last 3 months that is associated with at least 2 of the following Not usually associated with pain
  • Related to defecation
  • Change in stool frequency
  • Change in stool form
Loose or watery stools at least 25% of the time
Duration of more than three months Duration of more than three months

1.1. Diet Seeking Behaviour by Patients with Gastrointestinal Symptoms

Prior to seeing a health professional, patients often identify intolerance to specific foods or food groups, either by trial and error or through doing their own research. The internet has become a platform for seeking such advice [7]. A study comparing the advice provided in blogs by registered dietitians and non-dietitians (non-RD) such as certified holistic nutritionists, nutrition therapists, personal trainers and massage therapists found that non-RD most often provided specific nutrition advice on avoiding foods and promoting supplement use for health conditions including gut disorders [8]. The researchers also found that non-dietitian bloggers used fear-driven strategies and non-evidenced recommendations to support their advice. A survey of 1500 gastroenterologists at the American College of Gastroenterology found that almost 60% of patients seen had made dietary changes prior to their appointment with lactose-reduced and gluten-free diets being the most common [9]. A Swedish study of 197 IBS patients found that 84% reported at least one food as a trigger for their symptoms, with the number of foods identified as problematic increasing linearly in proportion to symptom severity [10]. Dairy and wheat products were commonly avoided [9][10].

1.2. Understanding the Role of Diet in the Management of Chronic Diarrhoea

There is a wide range of common causes of diarrhoea that can be classified depending on their responsiveness to dietary therapy (Table 2). The mechanisms for causing diarrhoea are varied and provide the basis for evidence-based dietary interventions. Often dietary therapy is part of a multidisciplinary approach to treat diarrhoea and may include drugs, gut-directed hypnotherapy or stress management. Figure 1 describes evidence-based approaches for the management of chronic diarrhoea.

Figure 1. Evidence-based approaches for the management of chronic diarrhoea.

Table 2. Common causes of chronic diarrhoea—pharmaceutical and dietary responsive.

Common Causes of Chronic Diarrhoea Mechanism Dietary Management
Predominantly pharmaceutical responsive
Pancreatic insufficiency Insufficient secretion of pancreatic digestive enzymes into the small intestine Teaching patients sources of fat so they are able to titrate digestive enzymes effectively
Microscopic colitis Inflammation occurring at a microscopic level in the lining of the large intestine N/A
Combination of pharmaceutical and dietary responsive
Short-bowel syndrome Reduced mucosal surface due to removal or damage of part of the small intestine Dietary manipulation to enhance absorption such as small frequent meals, higher protein and less refined sugar
Inflammatory bowel diseases Chronic intestinal inflammation occurring throughout the gastrointestinal tract Dietary and nutrition therapies to manage inflammation and promote maintenance of remission
Small intestinal bacterial overgrowth Overgrowth of colonic bacteria in the small intestine Restriction of fermentable carbohydrates (the low FODMAP diet) or an elemental diet may reduce overgrowth if antibiotics have not been responsive
Bile acid diarrhoea Excess bile acids entering the large intestine A low-fat diet may reduce the production of bile acids
Predominantly dietary responsive
Irritable bowel syndrome Mechanisms are not clearly understood but could be due to increased gut transit, visceral hypersensitivity or altered gut microbiome Dietary strategies could include: reducing portion sizes, regular eating, reducing fermentable carbohydrates or reducing natural food chemicals
Lactose intolerance Reduced lactase enzyme activity in the small intestine Limiting lactose-containing milk and milk products
Sucrase-isomaltase intolerance Reduced enzyme activity of sucrase and or isomaltase in the small intestine Reducing dietary intake of foods containing sucrose, isomaltose and maltose
Coeliac disease Genetic condition resulting in damage to the lining of the small intestine when gluten is consumed A strict lifelong gluten-free diet resolves symptoms and results in healing the lining of the small intestine

2. Dietary Management of Chronic Diarrhoea

2.1. Irritable Bowel Syndrome (IBS) and Functional Diarrhoea

Irritable bowel syndrome (IBS) affects 4–20% of the population [11]. Women are more likely than men to be diagnosed with IBS, and its prevalence, based on the Rome IV criteria (Table 1), is greater in the 30–45 year age group and for those living in Western countries [11]. IBS results in changes in bowel habits, bloating, pain and nausea. It also impacts energy levels [10] and quality of life [10][12] and is a common reason for visits to general practice [13], yet its aetiology remains unclear. IBS can persist for many years and develop at any age. A ten year follow-up study of over 8000 patients enrolled in a screening programme found that almost two-thirds of patients with IBS continued to have symptoms at follow up, while 28% of patients without symptoms at baseline subsequently developed IBS [14].

To diagnose IBS, abdominal pain must be present, and other gut-related causes eliminated such as coeliac disease, inflammatory bowel disease, colorectal cancer or diverticulitis. The Rome criteria classifies IBS as diarrhoea predominant (IBS–D), constipation predominant (IBS–C), mixed bowel habits (IBS-M) or unclassified (IBS-U) [15]. FD is diagnosed in those with diarrhoea but not abdominal pain.

2.1.1. Dietary Therapies for IBS

First-line dietary advice such as eating regularly, limiting intake of high-fibre food, reducing the intake of alcohol, caffeine, fizzy drinks and managing stress is sufficient to resolve IBS symptoms for up to 50% of patients [16][17]. If symptoms persist, a trial of an elimination diet to identify specific foods that trigger IBS symptoms may be warranted. There are a number of elimination diets described in the literature. The following sections outline three elimination diets, the evidence to support their use and the pearls and pitfalls of each dietary treatment (Table 3). Non-coeliac gluten sensitivity, which is often reported by patients, remains difficult to diagnose and define [18]. Patients may be reacting to other components within food such as fermentable carbohydrates [19][20]. Because this diet therapy is currently unproven it is not included in this review.

Table 3. The pearls and pitfalls of dietary therapies for the management of chronic diarrhoea.

 

Table 4. Pitfalls of the dietary management of chronic diarrhoea and management strategies.

 

This entry is adapted from the peer-reviewed paper 10.3390/nu13051393

References

  1. Arasaradnam, R.P.; Brown, S.; Forbes, A.; Fox, M.R.; Hungin, P.; Kelman, L.; Major, G.; O’Connor, M.; Sanders, D.S.; Sinha, R.; et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology. Gut 2018, 67, 1380–1399.
  2. Singh, P.; Mitsuhashi, S.; Ballou, S.; Rangan, V.; Sommers, T.; Cheng, V.; Iturrino-Moreda, J.; Friedlander, D.; Nee, J.; Lembo, A. Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. Am. J. Gastroenterol. 2018, 113, 593–600.
  3. Talley, N.J.; O’Keefe, E.A.; Zinsmeister, A.R.; Melton III, L.J. Prevalence of gastrointestinal symptoms in the elderly: A population-based study. Gastroenterology 1992, 102, 895–901.
  4. Gorospe, E.C.; Oxentenko, A.S. Nutritional consequences of chronic diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2012, 26, 663–675.
  5. McCoubrey, H.; Parkes, G.; Sanderson, J.; Lomer, M. Nutritional intakes in irritable bowel syndrome. J. Hum. Nutr. Diet. 2008, 21, 396–397.
  6. Ganda Mall, J.-P.; Östlund-Lagerström, L.; Lindqvist, C.M.; Algilani, S.; Rasoal, D.; Repsilber, D.; Brummer, R.J.; Keita, A.V.; Schoultz, I. Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? BMC Geriatr. 2018, 18, 75.
  7. Bianco, A.; Zucco, R.; Nobile, C.G.A.; Pileggi, C.; Pavia, M. Parents Seeking Health-Related Information on the Internet: Cross-Sectional Study. J. Med. Internet Res. 2013, 15, e204.
  8. Chan, T.; Drake, T.; Vollmer, R.L. A qualitative research study comparing nutrition advice communicated by registered Dietitian and non-Registered Dietitian bloggers. J. Commun. Health 2020, 13, 55–63.
  9. Lenhart, A.; Ferch, C.; Shaw, M.; Chey, W.D. Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists. J. Neurogastroenterol. Motil. 2018, 24, 437–451.
  10. Böhn, L.; Störsrud, S.; Törnblom, H.; Bengtsson, U.; Simrén, M. Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life. Am. J. Gastroenterol. 2013, 108, 634–641.
  11. Sperber, A.D.; Bangdiwala, S.I.; Drossman, D.A.; Ghoshal, U.C.; Simren, M.; Tack, J.; Whitehead, W.E.; Dumitrascu, D.L.; Fang, X.; Fukudo, S.; et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021, 160, 99–114.
  12. El-Salhy, M.; Østgaard, H.; Hausken, T.; Gundersen, D. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol. Med. Rep. 2012, 5, 1382–1390.
  13. Card, T.R.; Canavan, C.; West, J. The epidemiology of irritable bowel syndrome. Clin. Epidemiol. 2014, 6, 71–80.
  14. Ford, A.C.; Forman, D.; Bailey, A.G.; Axon, A.T.R.; Moayyedi, P. Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior. Am. J. Gastroenterol. 2008, 103, 1229–1239.
  15. Schmulson, M.J.; Drossman, D.A. What Is New in Rome IV. J. Neurogastroenterol. Motil. 2017, 23, 151–163.
  16. McKenzie, Y.A.; Bowyer, R.K.; Leach, H.; Gulia, P.; Horobin, J.; O’Sullivan, N.A.; Pettitt, C.; Reeves, L.B.; Seamark, L.; Williams, M.; et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J. Hum. Nutr. Diet. 2016, 29, 549–575.
  17. National Institute for Health Clinical Excellence. Irritable Bowel Syndrome in Adults: Diagnosis and Management of IBS in Primary Care. NICE. Available online: (accessed on 8 May 2018).
  18. Gibson, P.R.; Skodje, G.I.; Lundin, K.E.A. Non-coeliac gluten sensitivity. J. Gastroenterol. Hepatol. 2017, 32, 86–89.
  19. Ajamian, M.; Rosella, G.; Newnham, E.D.; Biesiekierski, J.R.; Muir, J.G.; Gibson, P.R. Effect of Gluten Ingestion and FODMAP Restriction on Intestinal Epithelial Integrity in Patients with Irritable Bowel Syndrome and Self-Reported Non-Coeliac Gluten Sensitivity. Mol. Nutr. Food Res. 2021, 65, 1901269.
  20. Biesiekierski, J.R.; Peters, S.L.; Newnham, E.D.; Rosella, O.; Muir, J.G.; Gibson, P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013, 145, 320–328.
  21. Halmos, E.P.; Gibson, P.R. Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome. J. Gastroenterol. Hepatol. 2019, 34, 1134–1142.
  22. Scarlata, K.; Catsos, P.; Smith, J. From a Dietitian’s Perspective, Diets for Irritable Bowel Syndrome Are Not One Size Fits All. Clin. Gastroenterol. Hepatol. 2020, 18, 543–545.
  23. De Roest, R.H.; Dobbs, B.R.; Chapman, B.A.; O'Brien, L.A.; Leeper, J.A.; Hebblethwaite, C.R.; Gearry, R.B. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int. J. Clin. Pract. 2013, 67, 895–903.
  24. Gill, S.K.; Rossi, M.; Bajka, B.; Whelan, K. Dietary fibre in gastrointestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 101–116.
  25. Moayyedi, P.; Andrews, C.N.; MacQueen, G.; Korownyk, C.; Marsiglio, M.; Graff, L.; Kvern, B.; Lazarescu, A.; Liu, L.; Paterson, W.G.; et al. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). J. Can. Assoc. Gastroenterol. 2019, 2, 6–29.
More
This entry is offline, you can click here to edit this entry!
ScholarVision Creations